DYAI
What one share of Dyadic International holds
Biological Products, (No Diagnostic Substances)
International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”), doing business as Dyadic Applied BioSolutions, is a global biotechnology company based in Jupiter, Florida, with operations in the United
Dyadic International’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.11 |
|---|---|
| Profit | −$0.21 |
| Cash and investments | $0.04 |
| Book value | −$0.07 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.03 | −$0.07 | — | −$0.06 | — | $1.76 |
| 2018 | $0.05 | −$0.21 | — | −$0.16 | — | $1.59 |
| 2019 | $0.06 | −$0.31 | — | −$0.21 | — | $1.31 |
| 2020 | $0.06 | −$0.34 | — | −$0.24 | — | $1.03 |
| 2021 | $0.09 | −$0.47 | — | −$0.41 | — | $0.65 |
| 2022 | $0.10 | −$0.34 | — | −$0.28 | — | $0.39 |
| 2023 | $0.10 | −$0.24 | — | −$0.23 | — | $0.20 |
| 2024 | $0.12 | −$0.20 | — | −$0.14 | — | $0.08 |
| 2025 | $0.09 | −$0.23 | — | −$0.17 | — | $0.03 |